MEDIGENE revenue breakdown overview

MEDIGENE revenue for the last year amounted to 5.58 M CHF, the most of which — 5.61 M CHF — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 30.92 M CHF. The greatest contribution to the revenue figure was made by Germany — last year it brought MEDIGENE 5.61 M CHF, and the year before that — 24.85 M CHF.